Medical release archive
Here you can find the archive of all Medical releases prior to 2022
Filter by date:
Showing 102 medical releases before 2023
-
New data show overuse of reliever medication in asthma is responsible for 250,000 tonnes of greenhouse gas emissions every year in the UK
-
medical release template
-
First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis
-
Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysis
-
Brilinta reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had an acute ischaemic stroke or transient ischaemic attack
-
Farxiga showed cardiovascular and renal benefit in patients with chronic kidney disease irrespective of cardiovascular disease status
-
Brilinta reduced subsequent disabling stroke or death in patients who had an acute ischaemic stroke or transient ischaemic attack in Phase III THALES trial sub-analysis
-
Anifrolumab reduces disease flares in patients with systemic lupus erythematosus while allowing oral corticosteroid tapering
-
Fasenra significantly reduced exacerbation rate for severe eosinophilic asthma patients in Phase IIIb ANDHI trial
-
AstraZeneca licenses preclinical porcupine inhibitor, RXC006, for idiopathic pulmonary fibrosis
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
